FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1510189850> ?p ?o ?g. }

• W1510189850 endingPage "93" @default.
• W1510189850 startingPage "87" @default.
• W1510189850 abstract "Abstract This multicentre study focused on monitoring imatinib mesylate (IMA) trough plasma (C trough ) and intracellular (IMA C intrac ) concentrations in 228 chronic myelogenous leukaemia patients. The median of measured IMA C trough in our patient group was 905.8 ng ml (range: 27.7–4628.1 ng/ml). We found a correlation between IMA C trough and alpha 1‐acid glycoprotein plasma concentrations ( rS = 0.42; p < 0.001). All other analysed parameters revealed only weak (gender, dose of IMA per kg) or not significant (age, albumin, creatinine plasma concentration or body mass index) impact on measured IMA C trough. The IMA C trough decreased during the first 6 months and significantly increased later during treatment. The IMA C trough at the first month of therapy did not differ between patients with and without an optimal response at the 12th ( p = 0.724) and 18th month ( p = 0.135) of therapy. There were no significant differences in medians of IMA C trough between both groups measured during the first year of treatment. The IMA C intrac during the first month were not different between patients with and without an optimal response at the 6th ( p = 0.273) and the 12th month ( p = 0.193) of therapy. Our data obtained from real life clinical practice did not find a benefit of routine and regular IMA C trough nor IMA C intrac therapeutic drug monitoring in chronic myelogenous leukaemia patients or for subsequent adjustments of the IMA dose based on these results. Moreover, actual alpha 1‐acid glycoprotein plasma concentration should be used for proper interpretation of IMA C trough results. Copyright © 2013 John Wiley & Sons, Ltd." @default.
• W1510189850 created "2016-06-24" @default.
• W1510189850 creator A5009675656 @default.
• W1510189850 creator A5018881192 @default.
• W1510189850 creator A5019949740 @default.
• W1510189850 creator A5036456788 @default.
• W1510189850 creator A5036912140 @default.
• W1510189850 creator A5037131671 @default.
• W1510189850 creator A5045455980 @default.
• W1510189850 creator A5053045969 @default.
• W1510189850 creator A5054654885 @default.
• W1510189850 creator A5066839326 @default.
• W1510189850 creator A5070518027 @default.
• W1510189850 creator A5072486477 @default.
• W1510189850 creator A5082994579 @default.
• W1510189850 creator A5084726862 @default.
• W1510189850 creator A5085743451 @default.
• W1510189850 date "2013-08-20" @default.
• W1510189850 modified "2023-10-11" @default.
• W1510189850 title "No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia" @default.
• W1510189850 cites W1964181017 @default.
• W1510189850 cites W1978821257 @default.
• W1510189850 cites W1980663284 @default.
• W1510189850 cites W1981251869 @default.
• W1510189850 cites W1988837929 @default.
• W1510189850 cites W1991593432 @default.
• W1510189850 cites W1993702149 @default.
• W1510189850 cites W2031630811 @default.
• W1510189850 cites W2050207895 @default.
• W1510189850 cites W2050646947 @default.
• W1510189850 cites W2055515709 @default.
• W1510189850 cites W2080241329 @default.
• W1510189850 cites W2091005492 @default.
• W1510189850 cites W2091409957 @default.
• W1510189850 cites W2140111850 @default.
• W1510189850 cites W2166654361 @default.
• W1510189850 doi "https://doi.org/10.1002/hon.2091" @default.
• W1510189850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23963760" @default.
• W1510189850 hasPublicationYear "2013" @default.
• W1510189850 type Work @default.
• W1510189850 sameAs 1510189850 @default.
• W1510189850 citedByCount "5" @default.
• W1510189850 countsByYear W15101898502014 @default.
• W1510189850 countsByYear W15101898502016 @default.
• W1510189850 countsByYear W15101898502017 @default.
• W1510189850 crossrefType "journal-article" @default.
• W1510189850 hasAuthorship W1510189850A5009675656 @default.
• W1510189850 hasAuthorship W1510189850A5018881192 @default.
• W1510189850 hasAuthorship W1510189850A5019949740 @default.
• W1510189850 hasAuthorship W1510189850A5036456788 @default.
• W1510189850 hasAuthorship W1510189850A5036912140 @default.
• W1510189850 hasAuthorship W1510189850A5037131671 @default.
• W1510189850 hasAuthorship W1510189850A5045455980 @default.
• W1510189850 hasAuthorship W1510189850A5053045969 @default.
• W1510189850 hasAuthorship W1510189850A5054654885 @default.
• W1510189850 hasAuthorship W1510189850A5066839326 @default.
• W1510189850 hasAuthorship W1510189850A5070518027 @default.
• W1510189850 hasAuthorship W1510189850A5072486477 @default.
• W1510189850 hasAuthorship W1510189850A5082994579 @default.
• W1510189850 hasAuthorship W1510189850A5084726862 @default.
• W1510189850 hasAuthorship W1510189850A5085743451 @default.
• W1510189850 hasConcept C112705442 @default.
• W1510189850 hasConcept C126322002 @default.
• W1510189850 hasConcept C126894567 @default.
• W1510189850 hasConcept C139719470 @default.
• W1510189850 hasConcept C141071460 @default.
• W1510189850 hasConcept C162324750 @default.
• W1510189850 hasConcept C19831878 @default.
• W1510189850 hasConcept C2776960273 @default.
• W1510189850 hasConcept C2777583451 @default.
• W1510189850 hasConcept C2778461978 @default.
• W1510189850 hasConcept C2778729363 @default.
• W1510189850 hasConcept C2780035454 @default.
• W1510189850 hasConcept C2780272996 @default.
• W1510189850 hasConcept C2780306776 @default.
• W1510189850 hasConcept C2909675724 @default.
• W1510189850 hasConcept C2910800852 @default.
• W1510189850 hasConcept C2911091166 @default.
• W1510189850 hasConcept C3020079912 @default.
• W1510189850 hasConcept C31785415 @default.
• W1510189850 hasConcept C32239851 @default.
• W1510189850 hasConcept C71924100 @default.
• W1510189850 hasConcept C90924648 @default.
• W1510189850 hasConcept C98274493 @default.
• W1510189850 hasConceptScore W1510189850C112705442 @default.
• W1510189850 hasConceptScore W1510189850C126322002 @default.
• W1510189850 hasConceptScore W1510189850C126894567 @default.
• W1510189850 hasConceptScore W1510189850C139719470 @default.
• W1510189850 hasConceptScore W1510189850C141071460 @default.
• W1510189850 hasConceptScore W1510189850C162324750 @default.
• W1510189850 hasConceptScore W1510189850C19831878 @default.
• W1510189850 hasConceptScore W1510189850C2776960273 @default.
• W1510189850 hasConceptScore W1510189850C2777583451 @default.
• W1510189850 hasConceptScore W1510189850C2778461978 @default.
• W1510189850 hasConceptScore W1510189850C2778729363 @default.
• W1510189850 hasConceptScore W1510189850C2780035454 @default.
• W1510189850 hasConceptScore W1510189850C2780272996 @default.
• W1510189850 hasConceptScore W1510189850C2780306776 @default.

• next